These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28965983)

  • 1. Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?
    Ben-Shachar D; Ene HM
    Biol Psychiatry; 2018 May; 83(9):770-779. PubMed ID: 28965983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial function in psychiatric disorders.
    Manji H; Kato T; Di Prospero NA; Ness S; Beal MF; Krams M; Chen G
    Nat Rev Neurosci; 2012 Apr; 13(5):293-307. PubMed ID: 22510887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting antioxidants to mitochondria: a new therapeutic direction.
    Sheu SS; Nauduri D; Anders MW
    Biochim Biophys Acta; 2006 Feb; 1762(2):256-65. PubMed ID: 16352423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pharmacological strategies for mitochondrial disorders.
    Kanabus M; Heales SJ; Rahman S
    Br J Pharmacol; 2014 Apr; 171(8):1798-817. PubMed ID: 24116962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Ben-Shachar D
    Schizophr Res; 2017 Sep; 187():3-10. PubMed ID: 27802911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy.
    Yang S; Han Y; Liu J; Song P; Xu X; Zhao L; Hu C; Xiao L; Liu F; Zhang H; Sun L
    Curr Med Chem; 2017; 24(29):3185-3202. PubMed ID: 28486920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Transplantation as a Novel Therapeutic Strategy for Mitochondrial Diseases.
    Park A; Oh M; Lee SJ; Oh KJ; Lee EW; Lee SC; Bae KH; Han BS; Kim WK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.
    Streck EL; Gonçalves CL; Furlanetto CB; Scaini G; Dal-Pizzol F; Quevedo J
    Braz J Psychiatry; 2014; 36(2):156-67. PubMed ID: 24845118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and type 2 diabetes.
    Rocha M; Apostolova N; Herance JR; Rovira-Llopis S; Hernandez-Mijares A; Victor VM
    Med Res Rev; 2014 Jan; 34(1):160-89. PubMed ID: 23650093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapies for mitochondrial diseases and current clinical trials.
    El-Hattab AW; Zarante AM; Almannai M; Scaglia F
    Mol Genet Metab; 2017 Nov; 122(3):1-9. PubMed ID: 28943110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant modulation in restoring mitochondrial function in neurodegeneration.
    Pahrudin Arrozi A; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
    Int J Neurosci; 2017 Mar; 127(3):218-235. PubMed ID: 27074540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of mitochondrial epilepsies.
    Rahman S
    Epilepsy Behav; 2019 Dec; 101(Pt B):106546. PubMed ID: 31677997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
    Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and psychiatric disorders.
    Jou SH; Chiu NY; Liu CS
    Chang Gung Med J; 2009; 32(4):370-9. PubMed ID: 19664343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mental illness in patients with inherited mitochondrial disorders.
    Rosebush PI; Anglin RE; Rasmussen S; Mazurek MF
    Schizophr Res; 2017 Sep; 187():33-37. PubMed ID: 28545943
    [No Abstract]   [Full Text] [Related]  

  • 16. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.
    Dare AJ; Phillips AR; Hickey AJ; Mittal A; Loveday B; Thompson N; Windsor JA
    Free Radic Biol Med; 2009 Dec; 47(11):1517-25. PubMed ID: 19715753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of melatonin in mitochondrial dysfunction and related disorders.
    Paradies G; Paradies V; Ruggiero FM; Petrosillo G
    Arch Toxicol; 2015 Jun; 89(6):923-39. PubMed ID: 25690732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Promoting Mitochondrial Transplantation Therapy.
    Yamada Y; Ito M; Arai M; Hibino M; Tsujioka T; Harashima H
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.
    Kasote DM; Hegde MV; Katyare SS
    Biofactors; 2013; 39(4):392-406. PubMed ID: 23460132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the literature on major mental disorders in adult patients with mitochondrial diseases.
    Fattal O; Budur K; Vaughan AJ; Franco K
    Psychosomatics; 2006; 47(1):1-7. PubMed ID: 16384802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.